Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

10.38
+0.54005.49%
Post-market: 10.15-0.2300-2.22%19:30 EDT
Volume:604.02K
Turnover:6.15M
Market Cap:200.76M
PE:-1.70
High:10.42
Open:9.97
Low:9.90
Close:9.84
52wk High:20.56
52wk Low:7.12
Shares:19.34M
Float Shares:17.42M
Volume Ratio:1.33
T/O Rate:3.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.96
PE(LYR):-1.76

Loading ...

U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings

Reuters
·
Apr 29

Corbus Pharmaceuticals Holdings Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $45

THOMSON REUTERS
·
Apr 29

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 29

Corbus Pharmaceuticals initiated with a Buy at Guggenheim

TIPRANKS
·
Apr 29

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Apr 25

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 23

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

GlobeNewswire
·
Apr 22

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 22

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 17

Corbus Pharmaceuticals Updates Executive Employment Agreements and Protections

TIPRANKS
·
Apr 17

Corbus CEO Cohen base salary rises to $673,625 under amended employment agreement

Reuters
·
Apr 17

Corbus Pharmaceuticals announces last person enrolled in CANYON-1 trial

TIPRANKS
·
Apr 14

Corbus enrolls last patient in Phase 1b CANYON-1 obesity trial of CRB-913

Reuters
·
Apr 14

Corbus Pharmaceuticals Holdings Inc - Canyon-1 Study on Track for Completion in Summer 2026

THOMSON REUTERS
·
Apr 14

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 14

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 10

Analysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI), Corbus Pharmaceuticals (CRBP) and Avita Medical (RCEL)

TIPRANKS
·
Apr 09

Corbus Pharmaceuticals Holdings Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
Apr 09

Corbus Pharmaceuticals (CRBP) Gets a Buy from Wedbush

TIPRANKS
·
Apr 08

Corbus Pharmaceuticals Holdings Inc. Stock Slips 4.2%, Underperforms Market

Dow Jones
·
Apr 08